GSK plays the white knight, paying $66M to rescue Spero's oral antibiotic after FDA rejection Servier severs CAR-T collab with Allogene, handing back rights outside the US to 3 candidates Rivus raises $132M series B as obesity, NASH prospects for metabolic drug heat up FDA slaps hold on DBV peanut allergy trial in call for protocol changes Small molecule stimulates axon growth in mice with severe spinal cord injury | 